PubMed Health⌕ Search

Biomedical subjects

C Flexner

Publications and source records attributed to C Flexner.

57 records · Page 4Linked to original sources

Prostaglandin and histamine involvement in the gastric vasodilator action of pentagastrin.

Male mongrel dogs were anesthetized with 30 mg/kg of pentobarbital and left gastric arterial blood flow (GBF) was measured with electromagnetic flow probes. Pentagastrin, 1microng/kg i.v., produced an initial brief increase in flow followed by a prolonged secondary increase. Histamine, 1 microng/kg, and prostaglandin E2, 0.5 microng/kg, produced monophasic short-lived increases in GBF. The histamine H1 antagonist diphenhydramine and the H2 antagonist metiamide did not affect resting GBF. The prostaglandin synthesis inhibitor, indomethacin, reduced resting GBF by 46%. Responses to histamine were blocked by diphenhydramine by 81% and reduced by indomethacin by 21%. Responses to prostaglandin E2 were reduced by indomethacin by 21%. The primary pentagastrin response was blocked by diphenhydramine by 54%. The secondary pentagastrin response was blocked by both metiamide by 69% and indomethacin by 71%. We conclude that GBF is maintained by a basal production of vasodilatory prostaglandins. Furthermore, pentagastrin can release histamine which by acting on H2 receptors can enhance the production and/or release of prostaglandins to finally mediate an increase in GBF. These actions may partly explain the deleterious effect of indomethacin and the curative effect of prostaglandins on gastric mucosal ulcers.

Animals↗

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.

Recombinant vaccinia viruses have been proposed as live vaccines against a variety of infectious diseases, including AIDS (acquired immune deficiency syndrome). Objections have been concerned primarily with side effects of the vaccinia virus vector itself. Recently it has been shown that inactivation of the vaccinia virus thymidine kinase gene or deletion of certain other non-essential genes is associated with a marked reduction in pathogenicity. Nevertheless, the ability of vaccinia virus to produce a progressive infection in immunodeficient individuals remains a most serious problem. Indeed, an incident of this type in a vaccinated man seropositive for human immunodeficiency virus was recently reported. We have used immunodeficient athymic nude mice to establish a model of disseminated vaccinia virus infection, and to demonstrate a novel approach to virus attenuation which involves insertion of a gene encoding human interleukin-2 into the genome of vaccinia virus vectors.

Animals↗